Skip to content

Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery

Early Identification and Prediction of Right Ventricular Dysfunction and Failure in Critically Ill Patients: An Observational Non-Interventional Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04092855
Acronym
PACEPORT
Enrollment
112
Registered
2019-09-17
Start date
2018-12-10
Completion date
2024-12-31
Last updated
2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure, Right Heart Failure, Right Ventricular Dysfunction

Keywords

Right Ventricular Pressure Waveform

Brief summary

RV dysfunction has been associated with increased mortality in the ICU and cardiac surgical patients. Thus, early identification of RV dysfunction at less severe stages will allow for earlier intervention and potentially better patient outcomes. However, so far, no studies have reported prospectively the prevalence of abnormal RV pressure waveform during cardiac surgery and in the ICU. The investigator's primary hypothesis is that the prevalence of abnormal RV pressure waveform occurs in more than 50% of cardiac surgical patients throughout their hospitalization. Those patients with abnormal RV pressure waveform will be more prone to post-operative complications related to RV dysfunction and failure in the OR and ICU.

Detailed description

Right ventricular (RV) dysfunction is mostly associated to a decrease in contractility, right ventricular pressure overload or right ventricular volume overload. RV dysfunction can occur in a number of clinical scenarios in the intensive care unit (ICU) and operating room (OR): pulmonary embolism, acute respiratory distress syndrome (ARDS), septic shock, RV infarction, and in pulmonary hypertensive patients undergoing cardiac surgery. Unfortunately, identifying which patients will develop RV dysfunction and then progress towards RV failure have proven difficult. One of the reasons for delaying the diagnosis of RV dysfunction could be the lack of uniform definition, especially in the perioperative period. Echocardiographic definitions of RV dysfunction have been described: RV fractional area change (RVFAC) \< 35 %, tricuspid annular plane systolic excursion (TAPSE) \< 16 mm, tissue Doppler S wave velocity \<10 cm/s, RV ejection fraction (RVEF) \<45% and RV dilation. However, echocardiographic indices alone are insufficient in describing RV function. The diagnosis of fulminant RV failure is more easily recognised as a combination of echocardiographic measures, compromised hemodynamic measures and clinical presentation. RV dysfunction is inevitably associated with absolute or relative pulmonary hypertension because of the anatomic and physiological connection between the RV and pulmonary vascular system. The gold standard for measuring pulmonary pressure is still the pulmonary artery catheter. However, RV output can initially be preserved despite of pulmonary hypertension. It is therefore mandatory that early, objective, continuous, easily obtainable and subclinical indices of RV dysfunction are found and validated to initiate early treatment of this disease.

Interventions

None listed

Sponsors

Edwards Lifesciences
CollaboratorINDUSTRY
Montreal Heart Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Male or female patients, age 18 and older, undergoing cardiac surgery and receiving standard of care monitoring utilizing a pulmonary artery catheter.

Exclusion criteria

* Emergency surgery or inability to obtain consent * Concomitant diseases such as pericardial constriction, congenital heart disease, severe valvular regurgitation, right ventricular systolic dysfunction, or right ventricular infarction.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of abnormal diastolic RV waveforms before CPB, after CPB and in the ICUFrom thermodilution catheter insertion until 2 hours after ICU arrivalAbnormal RV pressure waveform will be defined as a difference between the RV end-diastolic minus the early-diastolic pressure \> 4 mmHg.

Secondary

MeasureTime frameDescription
Proportion of patients with difficult and complex separation from cardiopulmonary bypass at the end of cardiac surgeryFrom the discontinuation of cardiopulmonary bypass until ICU arrival after surgery, assessed up to 4 hours.Difficult separation from cardiopulmonary bypass: instability requiring at least two different types of pharmacological agents (i.e., inotropes ± vasopressors ± inhaled agents) Complex separation from cardiopulmonary bypass: Hemodynamic instability requiring return on cardiopulmonary bypass or addition of mechanical support (intra-aortic balloon pump or extra-corporeal membrane oxygenator)
Cumulative time of Persistent Organ Dysfunction or Death (TPOD) during the first 28 days after cardiac surgeryUp to 28 days or until hospital dischargeTPOD is a continuous variable representative of the burden of care and morbidity during the first 28 days following cardiac surgery and was chosen to circumvent issues arising for using other clinical endpoint such as ICU length of stay
Incidence of deaths during hospitalisationUp to 30 days or until hospital dischargeDeath from any cause
Incidence of acute kidney injury (AKI)Up to 28 days or until hospital dischargeAcute kidney injury (AKI) according to KDIGO serum creatinine criteria: Stage 1: ≥50% or 27 umol/L increases in serum creatinine, Stage 2: ≥100% increase in serum creatinine, Stage 3 ≥200% increase in serum creatinine or an increase to a level of ≥254 umol/L or dialysis initiation.
Incidence of major bleedingUp to 28 days or until hospital dischargeMajor bleeding is defined by the Bleeding Academic Research Consortium (BARC) as one of the following: * Perioperative intracranial bleeding within 48h * Reoperation after closure of sternotomy for the purpose of controlling bleeding * Transfusion of ≥5 units of whole blood of packed red blood cells within a 48 hours period * Chest tube output ≥2L within a 24 hours period
Incidence of surgical reintervention for any reasonsUp to 28 days or until hospital dischargeRe-operation after the initial surgery for any cause
Incidence of deep sternal wound infection or mediastinitisUp to 28 days or until hospital dischargeDiagnosis of a deep incisional surgical site infection or mediastinitis by a surgeon or attending physician
Incidence of deliriumUp to 28 days or until hospital dischargeDelirium is defined as an intensive care delirium screening checklist (ICDSC) score(18) of ≥4 in the week following surgery or positive result for the Confusion Assessment Method for the ICU (CAM-ICU).
Incidence of strokeUp to 28 days or until hospital dischargeCentral neurologic deficit persisting longer than 72 hours
Total duration of ICU stay in hoursUp to 28 days or until hospital dischargeNumber of hours passed in the ICU
Duration of vasopressor requirements (in hours)Up to 28 days or until hospital dischargeVasopressors include norepinephrine, epinephrine, dobutamine, vasopressin, phenylephrine, milrinone, isoproterenol and dopamine.
Duration of hospital stay (in days)Up to 28 days or until hospital dischargeNumber of days hospitalized from the day of surgery to discharge
Duration of mechanical ventilation (in hours)Up to 28 days or until hospital dischargeA duration of \>24 hours will be considered prolonged ventilation requirements.
Incidence of major morbidity or mortalityUp to 28 days or until hospital dischargeIncluding death, prolonged ventilation, stroke, renal failure (Stage ≥2), deep sternal wound infection and reoperation for any reason.
Right ventricular ejection fractionFrom arrival to the operating room until 2 hours after ICU arrivalAssessed by the American Society of Echocardiography guidelines
Right ventricular fractional area changeFrom arrival to the operating room until 2 hours after ICU arrivalAssessed by the American Society of Echocardiography guidelines
Right ventricular strainFrom arrival to the operating room until 2 hours after ICU arrivalAssessed by the American Society of Echocardiography guidelines
Tricuspid annular plane systolic excursionFrom arrival to the operating room until 2 hours after ICU arrivalAssessed by the American Society of Echocardiography guidelines
Right ventricular performance indexFrom arrival to the operating room until 2 hours after ICU arrivalAssessed by the American Society of Echocardiography guidelines
Portal flow pulsatility fractionFrom arrival to the operating room until 2 hours after ICU arrivalDefined as the difference between the maximal and the minimal velocity during the cardiac cycle divided by the maximal velocity
Right ventricular stroke work indexFrom arrival to the operating room until 2 hours after ICU arrival0.0136x Stroke volume index x (Mean pulmonary artery pressure-mean right atrial pressure)
Relative pulmonary pressureFrom arrival to the operating room until 2 hours after ICU arrivalThe ratio of the mean systemic arterial pressure divided by the mean pulmonary artery pressure
Right ventricular function indexFrom arrival to the operating room until 2 hours after ICU arrivalDefined as (isovolumic contraction time + isovolumic relaxation time)/RV ejection time
Pulmonary artery pulsatility index (PAPi)From arrival to the operating room until 2 hours after ICU arrivalDefined as (systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/central venous pressure\]
Compliance of the pulmonary artery (CPA)From arrival to the operating room until 2 hours after ICU arrivalStroke volume divided by the pulmonary artery pulse pressure (systolic minus the diastolic pulmonary artery pressure)
Pulsatility of femoral venous flowFrom arrival to the operating room until 2 hours after ICU arrivalVelocity variations of blood flow in the femoral vein during the cardiac cycle

Countries

Canada

Contacts

Primary ContactSophie Robichaud, RRT
sophie.robichaud@icm-mhi.org5143763330
Backup ContactSamuel Côté, RRT
samuel.cote@icm-mhi.org5143763330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026